Severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2) is the most significant global health crisis of the 21st century. The aim of this study was to develop a model to simulate the effect of undocumented infections, seasonal infectivity, immunity, and non-pharmaceutical interventions (NPIs) on the transmission, morbidity, and mortality of SARS-CoV-2 in New York State (NYS) based on data collected between March 4 and April 28, 2020. Simulations predict that undocumented infections significantly contribute to infectivity, NPIs are effective in reducing morbidity and mortality, and relaxation >50% of NPIs from initial lock-down levels may result in tens-of-thousands more deaths. Endemic infection is likely to occur in the absence of sus...
A new bioinspired computational model was developed for the SARS-CoV-2 pandemic using the available ...
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic necessitated rapid local p...
Abstract Background As we continue the fourth year of the COVID-19 epidemic, SARS-CoV-2 infections s...
Background: The SARS-CoV-2 pandemic is spreading with a greater intensity across the globe. The sync...
We use COVID-19 case and mortality data from 1 February 2020 to 21 September 2020 and a deterministi...
Finding medications or vaccines that may decrease the infectious period of severe acute respiratory ...
Since its global emergence in 2020, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has...
Public health interventions such as social distancing and mask wearing decrease the incidence of sev...
Summary: Non-pharmaceutical interventions (NPIs) remain decisive tools to contain SARS-CoV-2. Strate...
During the 2003 Severe Acute Respiratory Syndrome (SARS) outbreak, traditional intervention measures...
To evaluate the role of anti-viral monoclonal antibodies (mAbs) in reducing SARS-CoV-2 transmission ...
Despite progress in clinical care for patients with coronavirus disease 2019 (COVID-19)1, population...
Vaccination and non-pharmaceutical interventions (NPIs) have been of central importance to mitigate ...
As of May 10, 2020, the United States of America (USA) has 1,367,079 cases of SARS CoV-2 and 80,773 ...
We use COVID-19 case and mortality data from 1 February 2020 to 21 September 2020 and a deterministi...
A new bioinspired computational model was developed for the SARS-CoV-2 pandemic using the available ...
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic necessitated rapid local p...
Abstract Background As we continue the fourth year of the COVID-19 epidemic, SARS-CoV-2 infections s...
Background: The SARS-CoV-2 pandemic is spreading with a greater intensity across the globe. The sync...
We use COVID-19 case and mortality data from 1 February 2020 to 21 September 2020 and a deterministi...
Finding medications or vaccines that may decrease the infectious period of severe acute respiratory ...
Since its global emergence in 2020, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has...
Public health interventions such as social distancing and mask wearing decrease the incidence of sev...
Summary: Non-pharmaceutical interventions (NPIs) remain decisive tools to contain SARS-CoV-2. Strate...
During the 2003 Severe Acute Respiratory Syndrome (SARS) outbreak, traditional intervention measures...
To evaluate the role of anti-viral monoclonal antibodies (mAbs) in reducing SARS-CoV-2 transmission ...
Despite progress in clinical care for patients with coronavirus disease 2019 (COVID-19)1, population...
Vaccination and non-pharmaceutical interventions (NPIs) have been of central importance to mitigate ...
As of May 10, 2020, the United States of America (USA) has 1,367,079 cases of SARS CoV-2 and 80,773 ...
We use COVID-19 case and mortality data from 1 February 2020 to 21 September 2020 and a deterministi...
A new bioinspired computational model was developed for the SARS-CoV-2 pandemic using the available ...
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic necessitated rapid local p...
Abstract Background As we continue the fourth year of the COVID-19 epidemic, SARS-CoV-2 infections s...